Q2867196 (Q2867196): Difference between revisions
Jump to navigation
Jump to search
(Changed an Item: Edited by the infer coords bot - inferring coordinates from location) |
(Changed an Item: Edited by the materialized bot - inferring region from the coordinates) |
||
Property / contained in NUTS | |||
Property / contained in NUTS: Coimbra Region / rank | |||
Normal rank |
Revision as of 21:34, 6 July 2021
Project Q2867196 in Portugal
Language | Label | Description | Also known as |
---|---|---|---|
English | No label defined |
Project Q2867196 in Portugal |
Statements
492,223.04 Euro
0 references
76.0 percent
0 references
1 April 2020
0 references
31 December 2020
0 references
LIMM THERAPEUTICS, SOCIEDADE ANÓNIMA
0 references
O projeto apresentado pela LiMM Therapeutics pretende avaliar a possibilidade de desenvolvimento de NRIL01 (reprogramadores neuronais de linfócitos inatos) na presença de SARS-CoV-2, contribuindo desta forma para minimizar as patologias renais como consequência da infeção com este vírus. (Portuguese)
0 references
Cantanhede
0 references
Identifiers
CENTRO-01-02B7-FEDER-069917
0 references